Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6207 USD | -1.87% | -7.36% | -16.75% |
04/04 | North American Morning Briefing : Focus Turns to -2- | DJ |
04/04 | Traws Pharma, Inc. Announces Chief Executive Office Changes | CI |
Sales 2024 * | 210K 17.51M | Sales 2025 * | 300K 25.01M | Capitalization | 13.09M 1.09B |
---|---|---|---|---|---|
Net income 2024 * | -23M -1.92B | Net income 2025 * | -28M -2.33B | EV / Sales 2024 * | 62.3 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 43.6 x |
P/E ratio 2024 * |
-0.72
x | P/E ratio 2025 * |
-0.75
x | Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.1% |
Latest transcript on Traws Pharma, Inc.
1 day | -1.87% | ||
1 week | -7.36% | ||
Current month | -38.54% | ||
1 month | -36.01% | ||
3 months | -12.17% | ||
6 months | +0.13% | ||
Current year | -16.75% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Fruchtman
PSD | President | 73 | 19/15/19 |
Mark Guerin
DFI | Director of Finance/CFO | 55 | 01/13/01 |
Meena Arora
CTO | Chief Tech/Sci/R&D Officer | - | 24/23/24 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Marino
BRD | Director/Board Member | 74 | 01/15/01 |
Jack Stover
BRD | Director/Board Member | 69 | 23/16/23 |
Mary Shoemaker
BRD | Director/Board Member | 63 | 01/20/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.6207 | -1.87% | 45,200 |
25/24/25 | 0.6326 | -1.38% | 30,679 |
24/24/24 | 0.6414 | -3.62% | 41,358 |
23/24/23 | 0.6655 | -0.82% | 55,839 |
22/24/22 | 0.671 | +0.15% | 44,722 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.75% | 13.09M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- TRAW Stock